Proton therapy for head and neck cancer

Current Opinion in Oncology

Volumn 27, Issue 3, 2015, Pages 165-171

  Lukens, J Nicholas ^a   Lin, Alexander ^a   Hahn, Stephen M ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

cost effectiveness research; head and neck cancer; intensity modulated proton therapy; protons; reirradiation

Indexed keywords

ACUTE TOXICITY; CANCER RADIOTHERAPY; CHONDROSARCOMA; CHORDOMA; COMPARATIVE EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; DISEASE FREE SURVIVAL; DOSIMETRY; HEAD AND NECK CANCER; HEALTH CARE COST; HUMAN; INTENSITY MODULATED PROTON THERAPY; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; LINEAR ENERGY TRANSFER; MORBIDITY; NASOPHARYNX CARCINOMA; NOSE CAVITY TUMOR; ORAL MUCOSITIS; OROPHARYNX CANCER; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PARANASAL SINUS TUMOR; PRIORITY JOURNAL; PROTON RADIATION; PROTON THERAPY; QUALITY OF LIFE; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION INJURY; RADIATION SAFETY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELATIVE BIOLOGIC EFFECTIVENESS; REVIEW; SKULL BASE TUMOR; SQUAMOUS CELL CARCINOMA; TUMOR VOLUME; XEROSTOMIA; COST BENEFIT ANALYSIS; DISEASE COURSE; HEAD AND NECK NEOPLASMS; ORGANS AT RISK; RADIATION RESPONSE; RADIOTHERAPY DOSAGE;

COST-BENEFIT ANALYSIS; DISEASE PROGRESSION; HEAD AND NECK NEOPLASMS; HUMANS; ORGANS AT RISK; PROTON THERAPY; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84928481375     PISSN: 10408746     EISSN: 1531703X     Source Type: Journal    
DOI: 10.1097/CCO.0000000000000181     Document Type: Review

References (37)

1. Nutting CM, Morden JP, Harrington KJ, et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 2011; 12:127-136.
2. Ling DC, Kabolizadeh P, Heron DE, et al. Incidence of hospitalization in patients with head and neck cancer treated with intensity-modulated radiation therapy. Head Neck 2014. [Epub ahead of print]
3. Hunter KU, Lee OE, Lyden TH, et al. Aspiration pneumonia after chemointensity-modulated radiation therapy of oropharyngeal carcinoma and its clinical and dysphagia-related predictors. Head Neck 2014; 36:120-125.
4. Holliday EB, Frank SJ. Proton radiation therapy for head and neck cancer: a review of the clinical experience to date. Int J Radiat Oncol Biol Phys 2014; 89:292-302.
5. Cozzi L, Fogliata A, Lomax A, Bolsi A. A treatment planning comparison of 3D conformal therapy, intensity modulated photon therapy and proton therapy for treatment of advanced head and neck tumours. Radiother Oncol 2001; 61:287-297.
6. van de Water TA, Bijl HP, Schilstra C, et al. The potential benefit of radiotherapy with protons in head and neck cancer with respect to normal tissue sparing: a systematic review of literature. Oncologist 2011; 16:366-377.
7. Lomax AJ, Goitein M, Adams J. Intensity modulation in radiotherapy: photons versus protons in the paranasal sinus. Radiother Oncol 2003; 66:11-18.
8. Widesott L, Pierelli A, Fiorino C, et al. Intensity-modulated proton therapy versus helical tomotherapy in nasopharynx cancer: planning comparison and NTCP evaluation. Int J Radiat Oncol Biol Phys 2008; 72:589-596.
9. Steneker M, Lomax A, Schneider U. Intensity modulated photon and proton therapy for the treatment of head and neck tumors. Radiother Oncol 2006; 80:263-267.
10. van der Laan HP, van de Water TA, van Herpt HE, et al. The potential of intensity-modulated proton radiotherapy to reduce swallowing dysfunction in the treatment of head and neck cancer: a planning comparative study. Acta Oncol 2013; 52:561-569.
11. Benghiat H, Cashmore J, Williams T, et al. Can protons or altered fractionation decrease neurotoxicity after chemoradiation in head and neck cancer? Clin Oncol 2014; 26:762-764.
12. Gulliford SL, Miah AB, Brennan S, et al. Dosimetric explanations of fatigue in head and neck radiotherapy: an analysis from the PARSPORT Phase III trial. Radiother Oncol 2012; 104:205-212.
13. Kandula S, Zhu X, Garden AS, et al. Spot-scanning beam proton therapy vs. intensity-modulated radiation therapy for ipsilateral head and neck malignancies: a treatment planning comparison. Med Dosim 2013; 38:390-394.
14. Ahn PH, Lukens JN, Teo BK, et al. The use of proton therapy in the treatment of head and neck cancers. Cancer J 2014; 20:421-426.
15. Lomax AJ. Intensity modulated proton therapy and its sensitivity to treatment uncertainties 2: the potential effects of inter-fraction and inter-field motions. Phys Med Biol 2008; 53:1043-1056.
16. Lomax AJ. Intensity modulated proton therapy and its sensitivity to treatment uncertainties 1: the potential effects of calculational uncertainties. Phys Med Biol 2008; 53:1027-1042.
17. Liu W, Frank SJ, Li X, et al. PTV-based IMPT optimization incorporating planning risk volumes vs. robust optimization. Med Phys 2013; 40:021709.
18. Zhu XR, Poenisch F, Li H, et al. A single-field integrated boost treatment planning technique for spot scanning proton therapy. Radiat Oncol 2014; 9:202.
19. Quan EM, Liu W, Wu R, et al. Preliminary evaluation of multifield and singlefield optimization for the treatment planning of spot-scanning proton therapy of head and neck cancer. Med Phys 2013; 40:081709.
20. Kraan AC, van de Water S, Teguh DN, et al. Dose uncertainties in IMPT for oropharyngeal cancer in the presence of anatomical, range, and setup errors. Int J Radiat Oncol Biol Phys 2013; 87:888-896.
21. Frank SJ, Cox JD, Gillin M, et al. Multifield optimization intensity modulated proton therapy for head and neck tumors: a translation to practice. Int J Radiat Oncol Biol Phys 2014; 89:846-853.
22. Noel G, Feuvret L, Calugaru V, et al. Chordomas of the base of the skull and upper cervical spine. One hundred patients irradiated by a 3D conformal technique combining photon and proton beams. Acta Oncol 2005; 44:700-708.
23. Ares C, Hug EB, Lomax AJ, et al. Effectiveness and safety of spot scanning proton radiation therapy for chordomas and chondrosarcomas of the skull base: first long-term report. Int J Radiat Oncol Biol Phys 2009; 75:1111-1118.
24. Resto VA, Chan AW, Deschler DG, Lin DT. Extent of surgery in the management of locally advanced sinonasal malignancies. Head Neck 2008; 30:222-229.
25. Truong MT, Kamat UR, Liebsch NJ, et al. Proton radiation therapy for primary sphenoid sinus malignancies: treatment outcome and prognostic factors. Head Neck 2009; 31:1297-1308.
26. Fukumitsu N, Okumura T, Mizumoto M, et al. Outcome of T4 (International Union Against Cancer Staging System, 7th edition) or recurrent nasal cavity and paranasal sinus carcinoma treated with proton beam. Int J Radiat Oncol Biol Phys 2012; 83:704-711.
27. Rombi B, Ares C, Hug EB, et al. Spot-scanning proton radiation therapy for pediatric chordoma and chondrosarcoma: clinical outcome of 26 patients treated at Paul Scherrer Institute. Int J Radiat Oncol Biol Phys 2013; 86:578-584.
28. Patel SH, Wang Z, Wong WW, et al. Charged particle therapy versus photon therapy for paranasal sinus and nasal cavity malignant diseases: a systematic review and meta-analysis. Lancet Oncol 2014; 15:1027-1038.
29. Frank SJ. Phase II/III Randomized Trial of Intensity-Modulated Proton Beam Therapy (IMPT) Versus Intensity-Modulated Photon Therapy (IMRT) for the Treatment of Oropharyngeal Cancer of the Head and Neck. Available from: https://clinicaltrials.gov/show/NCT01893307. [Accessed 12 December 2014].
30. McDonald MW, Linton OR, Shah MV. Proton therapy for reirradiation of progressive or recurrent chordoma. Int J Radiat Oncol Biol Phys 2013; 87:1107-1114.
31. Hutcheson K, Lewin JS, Garden AS, et al. Early experience with IMPT for the treatment of oropharyngeal tumors: acute toxicities and swallowing-related outcomes. Int J Radiat Oncol Biol Phys 2013; 87:S604.
32. Jagsi R, Bekelman JE, Brawley OW, et al. A research agenda for radiation oncology: results of the radiation oncology institutes comprehensive research needs assessment. Int J Radiat Oncol Biol Phys 2012; 84:318-322.
33. Ramaekers BL, Grutters JP, Pijls-Johannesma M, et al. Protons in head-andneck cancer: bridging the gap of evidence. Int J Radiat Oncol Biol Phys 2013; 85:1282-1288.
34. ASTRO Model Policies: Proton Beam Therapy. 2014; Available from: www.astro.org/uploadedFiles/Main-Site/Practice-Management/Reimbursement/ASTRO%20PBT%20Model%20Policy%20FINAL.pdf. [Accessed 18 August 2014].
35. Bekelman JE, Hahn SM. Reference pricing with evidence development: a way forward for proton therapy. J Clin Oncol 2014; 32:1540-1542.
36. Grassberger C, Trofimov A, Lomax A, Paganetti H. Variations in linear energy transfer within clinical proton therapy fields and the potential for biological treatment planning. Int J Radiat Oncol Biol Phys 2011; 80:1559-1566.
37. Paganetti H, van Luijk P. Biological considerations when comparing proton therapy with photon therapy. Semin Radiat Oncol 2013; 23:77-87.